The company was expecting a decision from the FDA by Sept. 28 for its oral drug tolebrutinib, but an update to the drug’s ...

AI Wealth Platform Goodfin Unveils that AI Can Now Master the Highest Levels of Financial Certification SAN FRANCISCO, Sept. 22, 2025 /PRNewswire/ -- ...

The American medicines regulator has delayed its decision on Sanofi’s (Euronext: SAN) tolebrutinib, an oral Bruton's tyrosine ...

In this video Kate has all three new Apple Watch devices and breaks down the differences between Apple Watch Series 11 vs. Apple Watch Ultra 3 vs. Apple Watch SE 3. You've got new features like the ...

AI-powered chatbots are coming under more scrutiny for the potential harms they may cause. Here's what educators need to know ...

Vijayawada: Fourstudents from Vikas College of Engineering and Technology located in Nunna of NTR district have been selected ...

SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or ...

Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...

For fans of The New York Times’ popular Connections puzzle, September 15, 2025, brings puzzle #827, offering a new set of ...

On the FDA’s docket for the back half of September is Merck’s proposed subcutaneous formulation of its blockbuster cancer drug Keytruda.

Recently, yet another Apollo astronaut, Jim Lovell, passed on. Lovell’s fame was as defined by his role as a pop culture icon ...